$2.59
-0.17[-6.16%]
Last update: 2:00PM Get Real Time Here
Armata Pharmaceuticals
(AMEX:ARMP)Latest News for Armata Pharmaceuticals Stock (AMEX:ARMP)
Armata Pharmaceuticals Stock (AMEX: ARMP)
Categories: All
Friday, March 22, 2024
Thursday, March 21, 2024
Monday, March 04, 2024
Wednesday, January 10, 2024
Tuesday, November 14, 2023
Tuesday, September 26, 2023
Tuesday, August 22, 2023
Monday, August 14, 2023
Thursday, July 27, 2023
Wednesday, July 26, 2023
- Why Universal Health Services Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Jul 26, 2023, 1:57PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Jul 26, 2023, 1:31PM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Jul 26, 2023, 9:06AM
Tuesday, July 25, 2023
Monday, July 24, 2023
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga Insights - Jul 24, 2023, 5:32PM
- Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Jul 24, 2023, 2:54PM
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Jul 24, 2023, 1:31PM
- Dow Surges 150 Points; Domino's Pizza Earnings Top ExpectationsLisa Levin - Jul 24, 2023, 10:45AM
Thursday, June 01, 2023
Thursday, May 18, 2023
- Why Monro Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - May 18, 2023, 1:19PM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - May 18, 2023, 9:07AM
- Why DLocal Shares Are Trading Lower By 11%; Here Are 20 Stocks Moving PremarketLisa Levin - May 18, 2023, 8:29AM
Friday, May 12, 2023
Monday, May 08, 2023
Friday, March 17, 2023
Thursday, March 16, 2023
Tuesday, March 07, 2023
Monday, March 06, 2023
- Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Mar 6, 2023, 1:25PM
- Investors Cheer Armata Pharma's Encouraging Data From Lung Infection CandidateVandana Singh - Mar 6, 2023, 11:39AM
- Armata Pharmaceuticals shares are trading higher after the company announced topline data from the Phase 1b/2a SWARM-P.a. clinical trial of inhaled AP-PA02 in patients with cystic fibrosis.Benzinga Newsdesk - Mar 6, 2023, 8:21AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Mar 6, 2023, 8:06AM
- Armata Pharmaceuticals Announced Topline Data from Phase 1b/2a SWARM-P.a. Clinical Trial of Inhaled AP-PA02 in Patients with Cystic FibrosisCharles Gross - Mar 6, 2023, 6:02AM